Worth the Wait Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients. by Sharon Tregaskis Our Own Words People with cancer and their loved ones find ways for their voices to be heard without filters. by Bradley Jones Survivor Profile Still in the Game ESPN reporter Holly Rowe worked through melanoma treatment. by Lindsey Konkel Q&A Dissecting Mental Illness Neuroscientist Barbara Lipska describes her experiences with symptoms of psychiatric illness caused by treatment for metastases in her brain. by Marci A. Landsmann Pembrolizumab Shows Further Promise for Melanoma In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected. by Brad Jones Forward Look Tackling Drug Resistance Researchers are studing new ways to keep treatments working longer. by Stephen Ornes Survivor Profile Living in the Here and Now A metastatic melanoma survivor is hopeful but realistic as new treatments become available. by Jenny Song Forward Look Cancer Immunotherapies Continue to Make Headway Drugs that harness the power of the immune system gain new approvals. by Alexandra Goho Survivor Profile Knowing Her Options When Christina McEvoy was diagnosed with stage IV melanoma, she took the reins of her care, traveling more than 600 miles for treatment and returning home to help other melanoma survivors. by Melissa Davlin First Person Keeping Sight of Hope A survivor keeps an eye on what's ahead after a rare cancer diagnosis. by Sue Russell next Cancer Talk Cancer Diagnoses and Research Continue Amid the ongoing pandemic, Cancer Today continues to cover cancer research and treatment while also reporting on the many ways COVID-19 has impacted people with cancer. by Kevin McLaughlin Planning to Survive Survivorship care plans can prepare cancer patients to get the best medical care and maintain their quality of life following treatment. by Carly Flumer Targeted Therapy for Early-Stage Lung Cancer? A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion. by Ashley P. Taylor Cervical Cancer Screening Guideline Updated A new version of the American Cancer Society’s cervical cancer screening guideline says screening can start at a later age and highlights human papillomavirus testing as the preferred method. by Anna Azvolinsky More Posts